Answers are grounded in this paper and cite their sources.
Humans encode 15 isoforms of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), which catalyzes the interconversion between CO 2 and bicarbonate and is involved in a multitude of physiological/pathological processes. CA inhibitors are in clinical use as diuretics, anti-glaucoma drugs, anti-epileptics, and anti-obesity agents. Novel applications as anti-tumor/anti-metastatic agents, or for the management of cerebral ischemia, rheumatoid arthritis, and neurodegenerative conditions, are discussed for the more than 45 chemotypes with inhibitory properties against these enzymes.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: